Laure Brulhart

946 total citations
22 papers, 526 citations indexed

About

Laure Brulhart is a scholar working on Rheumatology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Laure Brulhart has authored 22 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 5 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Laure Brulhart's work include Rheumatoid Arthritis Research and Therapies (16 papers), Viral Infections and Immunology Research (4 papers) and Musculoskeletal synovial abnormalities and treatments (4 papers). Laure Brulhart is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (16 papers), Viral Infections and Immunology Research (4 papers) and Musculoskeletal synovial abnormalities and treatments (4 papers). Laure Brulhart collaborates with scholars based in Switzerland, United States and Austria. Laure Brulhart's co-authors include Axel Finckh, Burkhard Möller, Cem Gabay, Diego Kyburz, Adrian Ciurea, Jean Dudler, Pascal Zufferey, Silvia Dehler, Sylvie Revaz and Giorgio Tamborrini and has published in prestigious journals such as Scientific Reports, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Laure Brulhart

20 papers receiving 517 citations

Peers

Countries citing papers authored by Laure Brulhart

Since Specialization

Citations

This map shows the geographic impact of Laure Brulhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laure Brulhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laure Brulhart more than expected).

Fields of papers citing papers by Laure Brulhart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laure Brulhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laure Brulhart. The network helps show where Laure Brulhart may publish in the future.

Co-authorship network of co-authors of Laure Brulhart

This figure shows the co-authorship network connecting the top 25 collaborators of Laure Brulhart. A scholar is included among the top collaborators of Laure Brulhart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laure Brulhart. Laure Brulhart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care 2023 ·Scientific Reports ·Myriam Riek, Almut Scherer, Burkhard Möller, Adrian Ciurea, (unknown), Cem Gabay, Diego Kyburz, Laure Brulhart, Johannes von Kempis, Ruediger B. Müeller, Paul Hasler, (unknown), (unknown), Pascal Zufferey, Jean Dudler, Axel Finckh	2
2	Éosinophilie chez des patients traités par tocilizumab dans le cadre d’une polyarthrite rhumatoïde 2022 ·Revue Médicale Suisse ·(unknown), (unknown), (unknown), Laure Brulhart	0
3	Does tenosynovitis of the hand detected by B-mode ultrasound predict loss of clinical remission in rheumatoid arthritis? Results from a real-life cohort 2022 ·Zurich Open Repository and Archive (University of Zurich) ·Raphael Micheroli, Almut Scherer, Kristina Bürki, Pascal Zufferey, Michael J. Nissen, Laure Brulhart, Burkhard Möller, Hans‐Rudolf Ziswiler, Adrian Ciurea, Giorgio Tamborrini	0
4	Greater trochanteric pain syndrome: predicting who will respond to a local glucocorticoid injection 2021 ·Scandinavian Journal of Rheumatology ·(unknown), D. Courvoisier, Antonio Faundez, Laure Brulhart, Axel Finckh, (unknown), Stéphane Genevay	5
5	Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland 2020 ·RMD Open ·Axel Finckh, Christoph Tellenbach, (unknown), Almut Scherer, (unknown), (unknown), (unknown), Cem Gabay, Diego Kyburz, Laure Brulhart, Rüdiger Müller, Paul Hasler, Pascal Zufferey	48
6	Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis 2019 ·RMD Open ·Laure Brulhart, D. Alpizar-Rodriguez, (unknown), Pascal Zufferey, (unknown), (unknown), Ilias Lazarou, Cem Gabay, Axel Finckh	15
7	Discordances between clinical and ultrasound measurements of disease activity among RA patients followed in real life 2019 ·Joint Bone Spine ·Pascal Zufferey, Delphine S. Courvoisier, Michael J. Nissen, Burkhard Möller, Laure Brulhart, (unknown), Giorgio Tamborrini, Adrian Ciurea, Maria Antonietta D’Agostino, Axel Finckh	4
8	Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years 2019 ·Lara D. Veeken ·Burkhard Möller, Daniel Aletaha, (unknown), Andrew Atkinson, Bérengère Aubry‐Rozier, Laure Brulhart, Diana Dan, Axel Finckh, (unknown), Péter Mandl, Raphael Micheroli, Michael J. Nissen, (unknown), Almut Scherer, Giorgio Tamborrini, Hans‐Rudolf Ziswiler, Pascal Zufferey	10
9	Glucocorticoid injections for greater trochanteric pain syndrome: a randomised double-blind placebo-controlled (GLUTEAL) trial 2018 ·Clinical Rheumatology ·Michael J. Nissen, Laure Brulhart, (unknown), Axel Finckh, Delphine S. Courvoisier, Stéphane Genevay	17
10	Can Ultrasound Be Used to Predict Loss of Remission in Patients with RA in a Real-life Setting? A Multicenter Cohort Study 2018 ·The Journal of Rheumatology ·Pascal Zufferey, Almut Scherer, Michael J. Nissen, Adrian Ciurea, Giorgio Tamborrini, Laure Brulhart, (unknown), (unknown), Burkhard Möller, (unknown)	10
11	The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis 2017 ·Clinical Rheumatology ·D. Alpizar-Rodriguez, Laure Brulhart, Ruediger B. Müeller, Burkhard Möller, Jean Dudler, Adrian Ciurea, Ulrich A. Walker, (unknown), Diego Kyburz, Pascal Zufferey, Michael Mähler, Sylvette Bas, (unknown), Céline Lamacchia, Pascale Roux‐Lombard, Kim Lauper, Michael J. Nissen, Delphine S. Courvoisier, Cem Gabay, Axel Finckh	17
12	FRI0522 Ultrasound-Detected Synovitis May Predict Radiographic Damage Progression in Rheumatoid Arthritis over The Next Five Years – A Prospective Cohort Study Nested in The Swiss Quality Management Program (SCQM) 2016 ·Annals of the Rheumatic Diseases ·Burkhard Möller, Pascal Zufferey, Laure Brulhart, Giorgio Tamborrini, Andreas Nydegger, Diana Dan, (unknown), Michael J. Nissen, (unknown), Axel Finckh, Bérengère Aubry‐Rozier, (unknown), (unknown), Andrew Atkinson, Almut Scherer	1
13	The importance of sonographer experience and machine quality with regards to the role of musculoskeletal ultrasound in routine care of rheumatoid arthritis patients. 2015 ·PubMed ·Laure Brulhart, Hans‐Rudolf Ziswiler, Giorgio Tamborrini, Pascal Zufferey	20
14	Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and/or the new ACR/EULAR RA remission definitions: Results of an observational cohort study 2014 ·Joint Bone Spine ·Pascal Zufferey, Burkhard Möller, Laure Brulhart, Giorgio Tamborrini, Almut Scherer, Axel Finckh, Hans‐Rudolf Ziswiler	35
15	Efficacy of intra-articular bevacizumab for relapsing diffuse-type giant cell tumour 2014 ·Annals of the Rheumatic Diseases ·Michael J. Nissen, Adam Boucher, Laure Brulhart, Jacques Ménétrey, Cem Gabay	13
16	Ultrasound evaluation of synovitis in RA: Correlation with clinical disease activity and sensitivity to change in an observational cohort study 2013 ·Joint Bone Spine ·Pascal Zufferey, Laure Brulhart, Giorgio Tamborrini, Axel Finckh, Almut Scherer, Burkhard Möller, Hans‐Rudolf Ziswiler	26
17	OP0275 Persistence of ultrasound synovitis in the patients fullfiling the DAS and/or the new ACR/EULAR RA remission definitions: Results of the sonar score applied to the patients of the SCQM cohort 2012 ·Annals of the Rheumatic Diseases ·Pascal Zufferey, Burkhard Möller, Laure Brulhart, Giorgio Tamborrini, Almut Scherer, (unknown)	5
18	Reproducibility and feasibility of a 22 joints ultrasound score in rheumatoid arthritis: a study among rheumatologists with diverse expertise in musculoskeletal ultrasound 2011 ·IRIS ·Laure Brulhart, Pascal Zufferey, Giorgio Tamborrini, (unknown), Thomas C. Gerber, Andreas Krebs, (unknown), (unknown)	3
19	Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? 2009 ·Annals of the Rheumatic Diseases ·Axel Finckh, Adrian Ciurea, Laure Brulhart, Burkhard Möller, Ulrich A. Walker, D. Courvoisier, Diego Kyburz, Jean Dudler, Cem Gabay	130
20	B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents 2007 ·Arthritis & Rheumatism ·Axel Finckh, Adrian Ciurea, Laure Brulhart, Diego Kyburz, Burkhard Möller, Silvia Dehler, Sylvie Revaz, Jean Dudler, Cem Gabay	156

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact